References
- Chhajed PN, famm M. (2003). Radiofrequency heat ablation for lung tumors: potential applications. Med Sci Monit 9:ED5–7.
- Fereidoun G. (2012). Radiofrequency ablation of lung tumors: imaging features of the postablation zone. RadioGraphics 32:947–69.
- Simon CJ, Dupuy DE, DiPetrillo TA, et al. (2007). Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268–75.
- Marine S, Bacharach SL, Buvat I. (2007). Partial-volume effect in PET tumor imaging UMR 678 INSERM-UPMC, CHU Pitie-Salpetrière, Paris, France. J Nucl Med 48:932–45.
- Okuma T, Okamura T, Matsuoka T, et al. (2006). Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 20:115–21.
- Higaki F, Okumura Y, Sato S, et al. (2008). Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor. Ann Nucl Med 22:157–63.
- Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. (1997). The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 157:849–55.
- Lee SH, Lee JM, Kim KW, et al. (2011). Dual-energy computed tomography to assess tumor response to hepatic radiofrequency ablation: potential diagnostic value of virtual noncontrast images and iodine maps. Invest Radiol 46:77–84.
- Park SY, Kim CK, Park BK. (2014). Dual-energy CT in assessing therapeutic response to radiofrequency ablation of renal cell carcinomas. Eur J Radiol 83:e73–9.
- Schmid-Bindert G, Henzler T, et al. (2012). Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? Eur Radiol 22:93–103.
- Schenzle JC1, Sommer WH, Neumaier K, et al. (2010). Dual energy CT of the chest: how about the dose? Invest Radiol 45:347–53.